Show results for
Refine by
Chemotherapy Suppliers In Germany
15 companies found
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tafasitamab (MOR208) is a humanized FC-modified CD19 targeting immunotherapy in clinical development for the treatment of B cell malignancies. CD19 is broadly expressed on the surface of B cells. It is therefore considered as a potential target for ...
based inBerlin, GERMANY
At SOMATEX, we design high quality single-use medical devices to facilitate diagnoses and therapies. That is how we contribute to making everyday life easier in the medical sector for users and patients. Our products are high quality, well thought ...
Q-shaped marker, Q-shape becomes firmly anchored in the tissue, Marker material is sandblasted and ...
based inBaldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
The human cyclin-dependent kinase inhibitor p16INK4a is a tumor antigen expressed in various cancers, including lung and breast cancer. In normal cells, p16INK4a is rarely expressed and leads to immediate senescence. In all cancers associated with ...
based inAthens, GREECE
Micrel Medical Devices SA is a medical technology company designing, manufacturing and marketing 'smart' drug delivery systems. We offer a full range of ambulatory volumetric and syringe infusion pumps, administration sets, accessories as well as ...
The MP 101+ is a simple and reliable syringe driver that provides infusion therapy for a wide range of applications. It is truly ambulatory with a robust design, trouble-free set up and accurate delivery in mm/hr. A clear informative display gives ...
based inWaldbuttelbrunn, GERMANY
In 2000, TauroPharm GmbH was founded as a German company specialising in medical devices with antimicrobial efficacy. We have since developed a variety of innovative products and built an international network. As TauroLock solutions have been ...
If you are looking for a catheter lock solution with both an antimicrobial and anticoagulant effect, we recommend TauroLock™. On this site, you can find detailed information about the product, its active ingredients, and ...
based inEssen, GERMANY
Medical technology can be directed towards an indication or to everyone concerned. We orientate ourselves accordingly. Naturally, the main focus is on the patient, especially where port catheters are concerned. Port systems are intended for ...
Titan-Port AS/PT (Ascites and peritoneal therapy) is a fully implantable port catheter system providing an access facility to the peritoneal space. The set contains a titanium port chamber with a self-sealing silicone membrane and a single-lumen ...
based inLund, SWEDEN
Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our ...
episil® oral liquid is a medical device for treatment of inflammatory and painful conditions in the oral cavity. The product provides fast pain relief and protection of sore and inflamed mucosal surfaces, as well as severe inflammation caused by ...
based inMunich, GERMANY
multimmune GmbH is a private, clinical-stage biopharmaceutical company which has developed a unique and proprietary technology platform for the development and clinical delivery of new cancer therapies on the basis of the founding scientists' ...
mi-APO is a targeted protein product with potential to be used for the treatment of most tumor types. The product targets surface-bound heat shock protein 70 (Hsp70). Surface-bound Hsp70 is a tumor-specific marker expressed on about 50-75% of ...
based inMunich, GERMANY
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide european-wide support in medical & clinical trial development for therapeutics and ...
Personalized medicine aims to identify patients who require treatment and subsequently select the right therapy based on individual factors and tumor characteristics, i.e. personalized medicine targets to identify the right patients for the right ...
based inEttlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...
The TheraBionic P1 produces low levels radiofrequency (RF) electromagnetic fields, which are amplitude-modulated at tumor-specific frequencies. The device is coupled with a spoon-shaped antenna, which is placed in the patient’s mouth, more ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Bone marrow deficiency refers to a condition in which the hematopoietic stem cells in the bone marrow fail to produce enough, or produce abnormal, red blood cells, white blood cells and platelets. Hematopoietic cell transplantation (HCT), the ...
based inMunchen, GERMANY
NeoControl provides a non-surgical, non-invasive therapy for treatment of: Erectile dysfunction, Premature ejaculation, Hemorrhoids, Urinary and feces Incontinence in both men and women, Incontinence after radical prostatectomy, Chronic prostatitis ...
Extracorporeal Magnetic Innervation (ExMI™) is based on the principle described by Faraday’s Law of Magnetic Induction. In the mid-1800s, Faraday demonstrated that muscular contractions could be induced by the application of a ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
Stem cell transplantation is a potentially curative procedure and an established therapeutic option for a number of diseases, primarily malignant diseases of the blood. In recent years, stem cell transplantation has also become an alternative ...
based inBlankenfelde-Mahlow, GERMANY
Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...